Six-month outcomes with a reduced two-injection induction (2+TAE) regimen of aflibercept 8 mg in treatment-naive neovascular age-related macular degeneration

Japanese Journal of Ophthalmology · Published 2026-07-31 · DOI 10.1007/s10384-026-01401-9

Free full text

Authors (20)

Nozomu Hashiya, Ichiro Maruko, Koji Tanaka, Junichiro Honjo, Yasunori Miyara, Yuto Watanabe, Ruka Maruko, Ayaka Nakai, Yu Wakatsuki, Kanako Itagaki, Marina Maehira, Nobuhiro Terao, Keiko Kataoka, Annabelle A. Okada, Hideki Koizumi, Ryo Mukai, Tetsuju Sekiryu, Ryusaburo Mori, for the Japan AMD Research Consortium (JARC), Tomohiro Iida

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Hashiya, N., Maruko, I., Tanaka, K., et al. (2026). Six-month outcomes with a reduced two-injection induction (2+TAE) regimen of aflibercept 8 mg in treatment-naive neovascular age-related macular degeneration. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-026-01401-9

Related articles